#isscr

Call for Abstracts. Avail early bird registration benefits on or before November 15 th, 2018. Quick Links. The Society Awards Program; Call for …

View full call or article at Google Alert – Call for abstracts

Blogging today’s FDA stem cell meeting: Part 2 Clinics, Policy & Ethics

The FDA is holding its first 2016 stem cell meeting today and you can read about some impressions of the morning session of this meeting here.

In this post, I’m focusing on the afternoon session, which has been mostly on policy and ethics, including on stem cell clinics.

Jonathan Kimmelman from McGill University got the afternoon going with his excellent talk “Ethics, Evidence, and Regulatory…

5 big picture stem cell trends at #ISSCR2016

Now that the ISSCR annual meeting is over, some overall stem cell trends are evident from the meeting in terms of the direction of the stem cell field. This was one of my favorite ISSCR meetings.

Translation expectation and upbeat tone. The overall vibe at the meeting was a sense of excitement and optimism about the field and where it stands in terms of advancing knowledge and translating stem…

New global guidelines for stem cell research

The International Society for Stem Cell Research (ISSCR), the world’s largest professional organization of stem cell scientists, today released newly updated guidelines for stem cellresearch and the development of new clinical therapies. The new guidance comes at a time when rapidly evolving technologies like gene editing in human embryos and emerging areas of stem cell discovery and its…

Monday morning musings: stem cell stocks, ISSCR, grants, CRISPR, New Book, & more

What’s on your mind on this Monday morning? Are you caffeinated enough yet? Depending on where you live it may even be time for dinner, bed, or already early Tuesday.

Here’s some musings…

To get safe and effective stem cell treatments to patients in a responsible, compliant manner you need commercial efforts and that in almost all cases means biotechs.

Doing this blog for 5+ years has made it…

Review of Biotech/Translational Talks #ISSCR2015: StemCells Inc, Semma, ViaCyte, & Le Blanc

By Heather Main

The path to the clinic is a slow and arduous activity, frustrating not only to the researcher and patient, but investors. Successful clinical translation of technologies requires a balance of science, streamlined translation and funding. To develop fantastic science and then realise the most important components cannot be adapted to the clinical environment is as disastrous as…

ISSCR calls for moratorium on clinical application of human germline nuclear genome editing

The International Society for Stem Cell Research (ISSCR) just now released a new policy statement on human germline gene editing.

The statement calls for a ban on clinical application of human germline gene editing technology.

Here is the brief summary statement at the beginning:

The International Society for Stem Cell Research calls for a moratorium on attempts at clinical application of nuclear…

Why I’m running to be on the ISSCR Board

The International Society for Stem Cell Research (ISSCR) is the top stem cell organization in the world.

It works to advance stem cell research and makes a major, positive difference. I want to do what I can to aid that mission of ISSCR.

For that reason, I am running for election to the Board of ISSCR for 2015.

As much as I believe that ISSCR is already fantastic, even something great can get…